ResApp Health Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Dec 08, 2021: ResApp establishes COVID-19 Scientific Advisory Board
Sep 14, 2021: ResApp receives advanced and overseas R&D finding
May 18, 2021: Brian Leedman reappointed as Executive Director
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The publisher's summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
ResApp Health Ltd (ResApp), a subsidiary of Pfizer Australia Holdings Pty Ltd, is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company’s products include SleepCheck, an at-home sleep apnoea screening app for customers to self-assess their risk of sleep apnoea; and ResAppDx-EU, a smartphone based acute respiratory disease diagnostic test for respiratory disease in adults and children. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp’s technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and telehealth use through partnerships with telehealth service providers. ResApp is headquartered in Brisbane, Queensland, Australia.ResApp Health Ltd Key Recent Developments
Dec 20, 2021: ResApp receives $818,826 in R&D tax incentive refundDec 08, 2021: ResApp establishes COVID-19 Scientific Advisory Board
Sep 14, 2021: ResApp receives advanced and overseas R&D finding
May 18, 2021: Brian Leedman reappointed as Executive Director
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company- ResApp Health Ltd - Key Facts
- ResApp Health Ltd - Key Employees
- ResApp Health Ltd - Key Employee Biographies
- ResApp Health Ltd - Major Products and Services
- ResApp Health Ltd - History
- ResApp Health Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- ResApp Health Ltd - Business Description
- ResApp Health Ltd - SWOT Analysis
- SWOT Analysis - Overview
- ResApp Health Ltd - Strengths
- ResApp Health Ltd - Weaknesses
- ResApp Health Ltd - Opportunities
- ResApp Health Ltd - Threats
- ResApp Health Ltd - Key Competitors
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- ResApp Health Ltd, Recent Deals Summary
- Dec 20, 2021: ResApp receives $818,826 in R&D tax incentive refund
- Dec 08, 2021: ResApp establishes COVID-19 Scientific Advisory Board
- Sep 14, 2021: ResApp receives advanced and overseas R&D finding
- May 18, 2021: Brian Leedman reappointed as Executive Director
- Mar 11, 2021: ResApp to progress clinical study to develop COVID-19 smartphone-based screening test
- Feb 04, 2021: ResApp receives $801,738 in R&D tax incentive refund and grant
- Jan 11, 2021: ResApp appoints VP, Commercial to progress growth strategy
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ResApp Health Ltd, Key Facts
- ResApp Health Ltd, Key Employees
- ResApp Health Ltd, Key Employee Biographies
- ResApp Health Ltd, Major Products and Services
- ResApp Health Ltd, History
- ResApp Health Ltd, Subsidiaries
- ResApp Health Ltd, Key Competitors
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- ResApp Health Ltd, Recent Deals Summary
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Welch Allyn Inc
- ResMed Inc
- Genetic Signatures Ltd
- GE Healthcare
- Alere Inc
